Investor Starboard’s
Sort by
15 items
-
Business - CNBC
Healthy Returns: What activist Starboard's $1 billion stake means for Pfizer
Pfizer's troubles may finally be coming to a head. Meanwhile, Hims & Hers is joining S&P SmallCap 600.5 hours ago -
Business - Financial Times
Pfizer chief Albert Bourla to meet activist investor Starboard Value
Fund run by Jeff Smith builds $1bn stake in vaccine maker and pitches shake-up plan5 hours ago -
Business - MarketWatch
Why stock investors shouldn’t worry about 10-year Treasury yield ruining 2024 rally yet
The benchmark 10-year Treasury yield, which finished above 4% for a second straight day on Tuesday, appears to be falling short of the levels needed to take the steam out of the 2024 U.S. stock rally.6 hours ago -
Business - CNBC
We're upgrading Honeywell after a long-awaited move. Jim Cramer says investors should act
The U.S. industrial firm unveiled plans Tuesday to spin off its advanced materials division.7 hours ago -
Business - MarketWatch
Pfizer’s bondholders cheer news of activist investor Starboard’s $1 billion investment
Pfizer Inc.’s stock gained Monday after a report that activist investor Starboard Value has invested $1 billion in the drug company. Bondholders seem to like the news too.10 hours ago -
Business - CNBC
Peru has attracted a slew of foreign investors into its credit market. Here's why
Foreign investors are eyeing Peru's debt market.10 hours ago -
World - ABC News
Hong Kong's Hang Seng index plunges 9.5% as investors dump shares after recent sharp gains
Hong Kong's Hang Seng index plunges 9.5% as investors dump shares after recent sharp gains17 hours ago -
Business - The Wall Street Journal
Why Pfizer Will Find It Hard to Appease Its Activist Investor
The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.22 hours ago -
Business - Financial Times
Former Pfizer CEO pitches board on Starboard’s shake-up plan
Ian Read has called his successors about the activist’s ideas for turning around the vaccine makerYesterday -
Business - CNBC
Bad call from Wall Street analysts on DuPont stock may be good news for investors
DuPont shares dropped Monday after Barclays downgraded the materials giant to a sell-equivalent rating and trimmed its price target.Yesterday -
Business - CNBC
GM investor day: Cruise, cash and EV profits top of mind for Wall Street
General Motors will attempt to address investor concerns at a capital markets day Tuesday that it can sustain, if not grow profits.Yesterday -
Business - CNBC
'It goes against all logic': Among the young and wealthy, cautious investors hold more crypto
Among investors age 21 to 43 with $3 million to invest, self-identified conservative investors hold more crypto than their more aggressive counterparts.Yesterday -
Business - The Wall Street Journal
Activist Starboard Value Takes $1 Billion Stake in Pfizer
The drugmaker’s shares have slumped as demand for Covid-19 vaccines and treatments has slowed.2 days ago -
Tech - The New York Times
CRV, a Venture Capital Firm, Will Return Money to Investors
CRV, based in Silicon Valley, plans to return to investors $275 million because the market for mature start-ups has soured.6 days ago